BOSTON–(BUSINESS WIRE)–Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that Sheldon Ng has joined the company’s Life Sciences Practice as a vice president. Mr. Ng will be based in the company’s San Francisco office.
“Sheldon has nearly 20 years of experience working with life sciences clients in support of their strategic planning, with particular expertise in market assessments, portfolio management, asset development, and global operations,” said Paul Maleh, CRA’s Chairman and Chief Executive Officer. “I am pleased to welcome him to CRA, where he will join a team that shares his multi-disciplinary capabilities and competencies, with a strong commitment to client engagement and organizational excellence.”
“Sheldon brings an innovative and analytical approach to his work,” said Dr. Gregory K. Bell, Group Vice President and Life Sciences Practice Leader. “Over the course of his career, he’s shown a keen ability to conduct creative and socially sensitive engagements that inspire clients and yield measurable results.”
Ng provides strategic consulting to life sciences clients on portfolio management, brand and launch planning, asset and lifecycle management, and organizational development. He has experience across multiple therapeutic areas, with deep expertise in oncology, cardiovascular, ophthalmology, respiratory, orphan diseases, and tissue and molecular diagnostics. Prior to joining CRA, Ng was a partner with a number of different life sciences strategy consulting firms in the San Francisco Bay Area. Ng launched and led strategy and business analytics practices specializing in the life sciences industry’s most critical issues.
Ng has an MBA in marketing and health care enterprise management from the Kellogg School of Management and a BA in biological sciences from Cornell University.
About CRA’s Life Sciences Practice
The CRA Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations. We provide the analytical expertise and industry experience needed to address our clients’ toughest issues. We have a reputation for rigorous and innovative analysis, careful attention to detail, and the ability to work effectively as part of a wider team of advisers.
About Charles River Associates (CRA)
Charles River Associates® is a leading global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at www.crai.com. Follow us on LinkedIn, Twitter, and Facebook.
SAFE HARBOR STATEMENT
Statements in this press release concerning the addition of Sheldon Ng, CRA’s Life Sciences Practice, the expansion of the Life Sciences Practice, and any future business or measurable results Mr. Ng may generate for CRA, are “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based upon management’s current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual performance or results to differ materially from any forward-looking statements made by CRA include, among others: the failure to generate engagements for us; the potential loss of clients; the demand environment; global economic conditions; foreign exchange rate fluctuations; and intense competition. Additional potential factors that could affect our financial results are included in our periodic filings with the Securities and Exchange Commission, including those under the heading “Risk Factors.” We cannot guarantee any future results, levels of activity, performance, or achievement. We undertake no obligation to update any forward-looking statements after the date of this press release, and we do not intend to do so.
Sharon Merrill Associates, Inc.